Literature DB >> 28539025

[Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis].

K L Kozlov1, I I Bolotov1, N S Linkova1,2, A O Drobintseva1, V Kh Khavinson1,3,4, M M Dyakonov1, L S Kozina1.   

Abstract

Peptide KED (Lys-Glu-Asp) has vasoprotective effects and is effective substance in treatment of of atherosclerosis and other cardio-vascular disorders in elderly people. One of the probable mechanisms of biological activity of this peptide is epigenetic genes regulation. These genes can coding proteins, which are markers of endothelium functional activity. The goal of investigation was to study the KED peptide effect on signal molecules expression in normal, atherosclerotic and restenotic endothelium in vitro. It was shown, that KED peptide has normalized endothelin-1 expression, which increased during atherosclerosis and restenosis. KED peptide also restorates cells interactions by connexin expression. Geroprotective effect of KED peptide is realized by increasing of sirtuin1 expression, which has took part in DNA reparation.

Entities:  

Keywords:  KED peptide; aging; atherosclerosis; endothelium; restenosis

Mesh:

Substances:

Year:  2016        PMID: 28539025

Source DB:  PubMed          Journal:  Adv Gerontol        ISSN: 1561-9125


  3 in total

1.  Peptide Regulation of Gene Expression: A Systematic Review.

Authors:  Vladimir Khatskelevich Khavinson; Irina Grigor'evna Popovich; Natalia Sergeevna Linkova; Ekaterina Sergeevna Mironova; Anastasiia Romanovna Ilina
Journal:  Molecules       Date:  2021-11-22       Impact factor: 4.411

Review 2.  Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers.

Authors:  Vladimir Khavinson; Natalia Linkova; Ekaterina Kozhevnikova; Anastasiia Dyatlova; Mikhael Petukhov
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

3.  Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease.

Authors:  Vladimir Khavinson; Anastasiia Ilina; Nina Kraskovskaya; Natalia Linkova; Nina Kolchina; Ekaterina Mironova; Alexander Erofeev; Michael Petukhov
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.